SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in Incyte Corporation of

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky Notifies Investors With 
Losses on Their Investment in Incyte Corporation of
Class Action Lawsuit and the May 6, 2013 Lead Plaintiff Deadline 
NEW YORK, NY -- (Marketwired) -- 04/05/13 --  Levi & Korsinsky
announces that a class action lawsuit has been commenced in the
United States District Court for the District of Delaware on behalf
of investors who purchased Incyte Corporation ("Incyte" or the
"Company") (NASDAQ: INCY) stock between April 26, 2012 and August 1,
2012 (the "Class Period"). 
For more information, click here: http://zlk.9nl.com/incyte-incy/.  
According to the complaint, Incyte's reported fourth quarter 2011 and
first quarter 2012 sales were artificially inflated due to a large
number of advanced-stage myelofibrosis patients being prescribed the
drug upon FDA approval in November 2011 -- patients who had been too
sick to participate in the clinical trials.  
On August 2, 2012, Incyte disclosed that Jakafi sales growth had been
much softer during the second quarter of 2012 than investors had been
led to expect. Defendants also disclosed that many of the new
patients prescribed Jakafi were so sick they would not have been
eligible for the Phase III trial. Defendants conceded that while
prescriptions to these patients had increased sales revenues, these
were not revenues that would continue for the suggested three years
on average that defendants claimed, as certain patients died. In
response to these disclosures, the price of Incyte stock fell from
its August 1, 2012 close of $24.92 per share to close at $19.57 per
share on August 2, 2012.  
If you suffered a loss in Incyte you have until May 6, 2013 to
request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn't require that you serve as a lead
plaintiff. To obtain additional information, contact Joseph E. Levi,
Esq. either via email at jlevi@zlk.com or by telephone at (877)
363-5972, or visit http://zlk.9nl.com/incyte-incy/. 
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, and Washington D.C. The firm has extensive expertise in
prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and
shareholder lawsuits. Attorney advertising. Prior results do not
guarantee similar outcomes. 
CONTACT: 
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004 
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com